Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.76% | 195.47 | 1.3% | $555.99m | |
| GILD | Gilead Sciences, Inc. | 0.24% | 66.52 | 0.9% | $368.70m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.79% | 107.40 | 2.0% | $321.44m | |
| ILMN | Illumina, Inc. | 1.14% | 300.91 | 3.5% | $301.00m | |
| BIIB | Biogen Inc. | 1.86% | 236.63 | 1.3% | $288.49m | |
| CELG | Celgene Corporation | -0.23% | 98.40 | 1.3% | $282.90m | |
| A | Agilent Technologies, Inc. | 0.43% | 77.90 | 1.6% | $193.04m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.25% | 86.00 | 14.7% | $180.31m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.44% | 174.94 | 1.9% | $173.66m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.90% | 281.62 | 2.6% | $171.53m | |
| EXAS | Exact Sciences Corporation | -1.82% | 106.71 | 24.1% | $132.03m | |
| ACAD | ACADIA Pharmaceuticals Inc. | 3.35% | 40.45 | 13.9% | $98.63m | |
| INCY | Incyte Corporation | 0.47% | 76.43 | 2.5% | $83.43m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.21% | 72.65 | 4.3% | $76.16m | |
| IONS | Ionis Pharmaceuticals, Inc. | -1.02% | 66.20 | 8.2% | $63.42m |
Company Profile
BioMarin Pharmaceutical, Inc. is a biotechnology company, which develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its products include Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq and Vimizim. The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.